The DOI matches its Crossref record.
RUCAM-based assessment of liver injury by xiang-tian-guo (Swietenia macrophylla) seeds, a plant used for treatment of hypertension and diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Therefore, lack of previous knowledge of liver injury does not prevent high causality gradings.”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [37]
The cited source says what the claim attributes to it.
In the citing paper
“Tan et al.37 also carefully assessed the comedicated drug using a separate RUCAM sheet, as recommended earlier.12,15”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [37]
In the citing paper
“In this study, most interesting was the finding of a high causality grading of probable, achieved with a score of 7”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [37]
In the citing paper
“As potential confounding alternative diagnosis, hepatitis E virus (HEV) infection was excluded in all three patients”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [37]
In the citing paper
“Similarly, lacking unintentional readministration, which provides a score of 0, nevertheless allowed for a high causality grading.37”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [37]
In the citing paper
“Similarly, in one of the largest studies of DILI with HILI published within the last year, little attention was paid to a separate robust listing of herbs causing liver injury in China.37”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 8
- Dewanjee, 2009, Swietenine: a potential oral hypoglycemic from Swietenia macrophylla seed, Fitoterapia, 80, 249, 10.1016/j.fitote.2009.02.004 · DOI
- Zhu, 2016, Hepatobiliary and pancreatic: comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients, J Gastroenterol Hepatol, 31, 1476, 10.1111/jgh.13323 · DOI · Paper page
- Teschke, 2016, Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs, Medicines, 3, 10.3390/medicines3030018 · DOI · Paper page
- Melchart, 1999, Liver enzyme elevations in patients treated with traditional Chinese medicine, JAMA, 282, 28, 10.1001/jama.282.1.28 · DOI
- Frenzel, 2016, Herbal hepatotoxicity: clinical characteristics and listing compilation, Int J Mol Sci, 17, 10.3390/ijms17050588 · DOI · Paper page
- Balijepalli, 2015, Acute oral toxicity studies of Swietenia macrophylla seeds in Sprague Dawley rats, Pharm Res, 7, 38
- Suzuki, 2011, The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury, Hepatology, 54, 931, 10.1002/hep.24481 · DOI · Paper page
- Danan, 1993, Causality assessment of adverse reactions to drugs – I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
Cited by
Sorted by citations
Teschke, R., Zhu, Y., & Jing, J. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00009 · Cited by 41
Metadata
- Authors
- Tan, Y., Chen, H., Zhou, X., & Sun, L.
- Venue
- Annals of Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 18
- Issue
- 2
- Pages
- 406-407
- ISSN
- 1665-2681
- Cited by
- 10
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
